It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EVH’s FA Score shows that 1 FA rating(s) are green while.
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EVH’s TA Score shows that 5 TA indicator(s) are bullish.
EVH (@Services to the Health Industry) experienced а -0.41% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -2.30%. For the same industry, the average monthly price growth was +4.52%, and the average quarterly price growth was +18.21%.
EVH is expected to report earnings on Oct 29, 2025.
This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
EVH | ||
---|---|---|
OUTLOOK RATING 1..100 | 60 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 67 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 95 | |
PRICE GROWTH RATING 1..100 | 61 | |
P/E GROWTH RATING 1..100 | 14 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EVH | GRX | |
---|---|---|
RSI ODDS (%) | N/A | 1 day ago82% |
Stochastic ODDS (%) | 1 day ago74% | 1 day ago75% |
Momentum ODDS (%) | 1 day ago83% | 1 day ago80% |
MACD ODDS (%) | 1 day ago73% | 1 day ago88% |
TrendWeek ODDS (%) | 1 day ago76% | 1 day ago86% |
TrendMonth ODDS (%) | 1 day ago74% | 1 day ago83% |
Advances ODDS (%) | 9 days ago78% | 4 days ago85% |
Declines ODDS (%) | 3 days ago77% | 11 days ago81% |
BollingerBands ODDS (%) | 1 day ago76% | N/A |
Aroon ODDS (%) | 1 day ago75% | 1 day ago82% |
A.I.dvisor tells us that GRX and JNJ have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GRX and JNJ's prices will move in lockstep.